107 related articles for article (PubMed ID: 6602720)
1. Proliferation of human B lymphocytes mediated by a soluble factor.
Maizel A; Mehta S; Kouttab N; Morgan J; Ford R; Sahasrabuddhe C
Fed Proc; 1983 Jul; 42(10):2753-6. PubMed ID: 6602720
[TBL] [Abstract][Full Text] [Related]
2. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
3. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
Lipkowitz S; Rubin AL; Stenzel KH; Novogrodsky A
J Immunol; 1983 Jun; 130(6):2702-7. PubMed ID: 6602177
[TBL] [Abstract][Full Text] [Related]
4. B cell growth factor and T cell growth factor produced by mitogen-stimulated normal human peripheral blood T lymphocytes are distinct molecules.
Muraguchi A; Kasahara T; Oppenheim JJ; Fauci AS
J Immunol; 1982 Dec; 129(6):2486-9. PubMed ID: 6982927
[TBL] [Abstract][Full Text] [Related]
5. Functional properties of two human B cell growth factor species separated by lectin affinity column.
Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
[TBL] [Abstract][Full Text] [Related]
6. Biochemical separation of a human B cell mitogenic factor.
Maizel A; Sahasrabuddhe C; Mehta S; Morgan J; Lachman L; Ford R
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5998-6002. PubMed ID: 6985268
[TBL] [Abstract][Full Text] [Related]
7. Lectin extracts of champedak seeds demonstrate selective stimulation of T lymphocyte proliferation.
Hashim OH; Gendeh GS; Jaafar MI
Biochem Int; 1992 Jun; 27(1):139-43. PubMed ID: 1627170
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
[TBL] [Abstract][Full Text] [Related]
9. Purification and partial characterization of human intracellular B cell growth factor.
Sahasrabuddhe CG; Martin B; Maizel AL
Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
[TBL] [Abstract][Full Text] [Related]
10. Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production.
Fleisher TA; Greene WC; Blaese RM; Waldmann TA
J Immunol; 1981 Mar; 126(3):1192-7. PubMed ID: 6450804
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
[TBL] [Abstract][Full Text] [Related]
12. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
13. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
Booth RJ; Prestidge RL; Watson JD
J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
[TBL] [Abstract][Full Text] [Related]
14. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.
Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K
J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079
[TBL] [Abstract][Full Text] [Related]
15. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
Mongini PK; Highet PF; Inman JK
J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
Butler JL; Ambrus JL; Fauci AS
J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
[TBL] [Abstract][Full Text] [Related]
17. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
18. Identification and partial purification of a B cell growth-promoting material utilizing the BCL1 cell line.
Thoman ML; Weigle WO
J Immunol; 1983 Jan; 130(1):233-6. PubMed ID: 6600179
[TBL] [Abstract][Full Text] [Related]
19. Human immunoregulatory molecules: interleukin 1, interleukin 2, and B-cell growth factor.
Lachman LB; Maizel AL
Contemp Top Mol Immunol; 1983; 9():147-67. PubMed ID: 6603332
[No Abstract] [Full Text] [Related]
20. The extracts from Nelumbo Nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells.
Liu CP; Tsai WJ; Lin YL; Liao JF; Chen CF; Kuo YC
Life Sci; 2004 Jun; 75(6):699-716. PubMed ID: 15172179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
